✦ LIBER ✦

Yeast cells as tools for target-oriented screening

✍ Scribed by T. Munder; A. Hinnen

Book ID: 105954671
Publisher: Springer
Year: 1999
Tongue: English
Weight: 202 KB
Volume: 52
Category: Article
ISSN: 1432-0614
DOI: 10.1007/s002530051525

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phage display as a novel screening tool

Phage display as a novel screening tool for primary toxicological targets

✍ Bieke Van Dorst; Wim De Coen; Ronny Blust; Johan Robbens 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract In the present study the use of phage display as a screening tool to determine primary toxicological targets was investigated. These primary toxicological targets are the targets in the cell with which a chemical compound initially interacts and that are responsible for consecutive (tox

Pharmacogenetic tools for the developmen

Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs

✍ Apud, José A. ;Weinberger, Daniel R. 📂 Article 📅 2006 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 177 KB

Furans as Versatile Synthons for Target-

Furans as Versatile Synthons for Target-Oriented and Diversity-Oriented Synthesis

✍ Dennis L. Wright 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

Screening yeast cells for absorption of

Screening yeast cells for absorption of selenium oxyanions

✍ Mohammad Reza Soudi; Fereydoon Malekzadeh; Parviz Norouzi 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 99 KB

Commentary: screening as a tool for enga

Commentary: screening as a tool for engagement

✍ Chasnoff, I J; McGourty, R 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 37 KB

Immune cells as anti-cancer therapeutic

Immune cells as anti-cancer therapeutic targets and tools

✍ Magnus Johansson; Tingting Tan; Karin E. de Visser; Lisa M. Coussens 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract Chronic inflammation is a contributing factor to overall cancer risk as well as cancer promotion and progression; however, pathways regulating onset of cancer‐promoting inflammatory responses are still poorly understood. Clinical data suggest that deficient anti‐tumor cell‐mediated immu